NCT00406809

A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies

Public trial-level signal summary for this oncology Phase 2 record.

Record overview

Status and phase

Status: COMPLETED

Phase: PHASE1, PHASE2

Sponsor: AbbVie (prior sponsor, Abbott)

Condition: Chronic Lymphoid Leukemia, Lymphoid Malignancies, Non-Hodgkin's Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Peripheral T-cell Lymphoma

Signal summary

Public flags

Status signal: Low Signal

Timeline signals: stale_update_signal

Results signal: Completed No Results Found Signal

Operational burden: rare_population_signal | strict_eligibility_signal

Stopped reason

Context when available

No stop reason available in the current public record.